title: Sir Michael Rawlins on being NICE--and fair--about drug development and availability. Interview by Daniel Clarke.
authors.forename: Sir Michael
authors.initials: SM
authors.lastname: Rawlins
mesh_terms: D003362:Cost-Benefit Analysis / Q000191:economics / Q000331:legislation & jurisprudence; D017277:Drug Approval / Q000458:organization & administration*; D016527:Drug Costs / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D006801:Humans; D004364:Pharmaceutical Preparations / Q000191:economics*; D006113:United Kingdom
chemical_list: D004364:Pharmaceutical Preparations